SNN expression based on
|
KIRP : Kidney renal papillary cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 8.47449888041751E-11 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
2.86037860064425E-12 |
Normal-vs-Stage2 |
2.023700E-03 |
Normal-vs-Stage3 |
2.630400E-02 |
Normal-vs-Stage4 |
1.72059999581364E-09 |
Stage1-vs-Stage2 |
2.000600E-01 |
Stage1-vs-Stage3 |
7.084500E-02 |
Stage1-vs-Stage4 |
1.560240E-01 |
Stage2-vs-Stage3 |
5.462200E-01 |
Stage2-vs-Stage4 |
2.099600E-02 |
Stage3-vs-Stage4 |
5.064900E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
8.24750268080265E-11 |
Normal-vs-AfricanAmerican |
2.76960000045179E-07 |
Normal-vs-Asian |
2.242400E-04 |
Caucasian-vs-AfricanAmerican |
8.662800E-01 |
Caucasian-vs-Asian |
6.081400E-01 |
AfricanAmerican-vs-Asian |
7.272600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
3.22799564855814E-11 |
Normal-vs-Female |
3.65789999956512E-07 |
Male-vs-Female |
3.164800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
Descriptions |
Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Normal_Weight |
8.55519999953813E-07 |
Normal-vs-Extreme_Weight |
8.49470493946569E-11 |
Normal-vs-Obese |
2.88000000003841E-06 |
Normal-vs-Extreme_Obese |
1.003990E-02 |
Normal_Weight-vs-Extreme_Weight |
9.019800E-01 |
Normal_Weight-vs-Obese |
3.258000E-01 |
Normal_Weight-vs-Extreme_Obese |
8.006000E-01 |
Extreme_Weight-vs-Obese |
2.435000E-01 |
Extreme_Weight-vs-Extreme_Obese |
8.040200E-01 |
Obese-vs-Extreme_Obese |
7.389600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
4.859300E-03 |
Normal-vs-Age(41-60Yrs) |
1.04299999748036E-08 |
Normal-vs-Age(61-80Yrs) |
2.14089856953592E-11 |
Normal-vs-Age(81-100Yrs) |
1.04030000169786E-08 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.685600E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.588000E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.145800E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.027000E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.461900E-02 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.414640E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-VS-Type1 PRCC |
2.8057556278327E-12 |
Normal-VS-Type2 PRCC |
3.06060000010433E-07 |
Normal-VS-KIRP CIMP |
2.48009999981313E-07 |
Normal-VS-Unclassified PRCC |
2.529600E-02 |
Type1 PRCC-VS-Type2 PRCC |
2.332800E-01 |
Type1 PRCC-VS-KIRP CIMP |
5.170600E-01 |
Type1 PRCC-VS-Unclassified PRCC |
9.843700E-04 |
Type2 PRCC-VS-KIRP CIMP |
1.152210E-01 |
Type2 PRCC-VS-Unclassified PRCC |
7.849500E-02 |
KIRP CIMP-VS-Unclassified PRCC |
5.602300E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
7.58629999930704E-08 |
Normal-vs-N1 |
1.7852999999457E-06 |
Normal-vs-N2 |
5.554800E-04 |
N0-vs-N1 |
7.025600E-01 |
N0-vs-N2 |
5.425000E-01 |
N1-vs-N2 |
3.781800E-01 |
|
|